A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors
Clinical trial NCT02923349 · COMPLETED
Trial details
- NCT number
- NCT02923349
- Sponsor
- Incyte Biosciences International Sàrl
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2019-03-26
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.